SCHEMBL4907204

SCHEMBL4907204

C=CCOC(=O)C(C[C@H]1C(CC)C(CC)[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 1/20 0.48
PSEN2 P49810 1/20 0.48
APH1B Q8WW43 1/20 0.48
NCSTN Q92542 1/20 0.48
APH1A Q96BI3 1/20 0.48
PSENEN Q9NZ42 1/20 0.48
CYP3A4 P08684 9/20 0.46
LMNA P02545 8/20 0.46
MAPT P10636 6/20 0.46
TSHR P16473 5/20 0.46
NR3C1 P04150 4/20 0.46
PGR P06401 4/20 0.46
AR P10275 4/20 0.46
CYP2C9 P11712 3/20 0.46
NR1I2 O75469 2/20 0.46
CYP2C19 P33261 2/20 0.46
CYP17A1 P05093 2/20 0.46
OPRK1 P41145 1/20 0.46
ALDH1A1 P00352 6/20 0.45
SMN1; SMN2 Q16637 5/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4876813 0.89 CYP3A4 (0.52) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL4907194 0.81 PSEN1 (0.47) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL4885697 0.79 CYP3A4 (0.52) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL3384546 0.77 SHBG (0.48) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL3275157 0.77 CYP3A4 (0.55) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL10748724 0.73 PSEN1 (0.79) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL10748729 0.73 PSEN1 (0.79) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL3387445 0.73 SHBG (0.46) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL11791262 0.73 PSEN1 (0.68) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL3747284 0.71 CYP17A1 (0.54) CYP3A4LMNAMAPTTSHRNR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080194812-A1 Process for the Preparation of 17-Hydroxy-6Beta, 7Beta; 15Beta, 16Beta-Bismethylene- 17Alpha-Pregn-4-Ene-3-One-21-Carboxylic Acid Y-Lactone and Key Intermediates for this Process RICHTER GEDEON VEGYESZETI GYAR RT. (HU) 2008-08-14 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194812-A1 Process for the Preparation of 17-Hydroxy-6Beta, 7Beta; 15Beta, 16Beta-Bismethylene- 17Alpha-Pregn-4-Ene-3-One-21-Carboxylic Acid Y-Lactone and Key Intermediates for this Process CYP17A1, HSD17B7, HSD17B11 PSEN1 2435/4885PSEN2 2891/4885APH1B 464/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.